| Line item | 2025-11-30 FY | 2024-11-30 FY | 2023-11-30 FY | 2022-11-30 FY | 2021-11-30 FY |
|---|---|---|---|---|---|
| Revenue | $8.00K | $1.25M | $113.41K | $15.00K | $28.50K |
| Cost of Revenue | – | – | – | – | $1.48K |
| Gross Profit | – | – | $113.41K | $15.00K | $27.02K |
| Operating Expenses | $312.92K | $398.36K | $415.06K | $363.27K | $247.22K |
| R&D | – | – | – | – | – |
| SG&A | $312.92K | $398.36K | $415.06K | $363.27K | $247.22K |
| Operating Income | -$304.92K | $851.53K | -$301.65K | -$348.27K | -$220.19K |
| Interest Expense | $9.57K | $3.04K | – | – | – |
| Tax Expense | -$91.89K | – | $0.00 | $0.00 | $0.00 |
| Net Income | -$943.44K | $642.21K | -$500.40K | -$1.71M | -$9.77M |
| EPS (basic) | 0.0200 | -0.0300 | -0.0200 | -0.0600 | -0.3500 |
| EPS (diluted) | 0.0200 | -0.0300 | -0.0200 | -0.0600 | -0.3500 |
| Shares (diluted) | $27.94M | $27.94M | – | – | $28.04M |